CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 43 | -18.9% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 53 | +65.6% | 0.00% | – |
| Q3 2019 | $1,000 | -97.6% | 32 | -98.8% | 0.00% | -100.0% |
| Q2 2019 | $42,000 | +10.5% | 2,663 | -6.1% | 0.01% | +25.0% |
| Q4 2018 | $38,000 | +280.0% | 2,836 | +291.7% | 0.01% | +300.0% |
| Q3 2018 | $10,000 | -75.6% | 724 | -72.8% | 0.00% | -77.8% |
| Q2 2018 | $41,000 | -6.8% | 2,663 | 0.0% | 0.01% | -10.0% |
| Q1 2018 | $44,000 | – | 2,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |